vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and BlackSky Technology Inc. (BKSY). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $35.2M, roughly 1.3× BlackSky Technology Inc.). BlackSky Technology Inc. runs the higher net margin — -2.5% vs -19.9%, a 17.5% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 15.9%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 20.5%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
BlackSky Technology Inc. is a leading geospatial intelligence provider operating a constellation of high-revisit small Earth observation satellites. It delivers real-time satellite imagery, advanced data analytics, and dynamic monitoring solutions to government, defense, critical infrastructure, and commercial clients globally to support data-driven operational decision-making.
ABCL vs BKSY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $35.2M |
| Net Profit | $-8.9M | $-868.0K |
| Gross Margin | — | — |
| Operating Margin | -63.7% | -11.8% |
| Net Margin | -19.9% | -2.5% |
| Revenue YoY | 788.4% | 15.9% |
| Net Profit YoY | 73.9% | 95.5% |
| EPS (diluted) | $-0.03 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $35.2M | ||
| Q3 25 | $9.0M | $19.6M | ||
| Q2 25 | $17.1M | $22.2M | ||
| Q1 25 | $4.2M | $29.5M | ||
| Q4 24 | $5.0M | $30.4M | ||
| Q3 24 | $6.5M | $22.5M | ||
| Q2 24 | $7.3M | $24.9M | ||
| Q1 24 | $10.0M | $24.2M |
| Q4 25 | $-8.9M | $-868.0K | ||
| Q3 25 | $-57.1M | $-15.3M | ||
| Q2 25 | $-34.7M | $-41.2M | ||
| Q1 25 | $-45.6M | $-12.8M | ||
| Q4 24 | — | $-19.4M | ||
| Q3 24 | $-51.1M | $-12.6M | ||
| Q2 24 | $-36.9M | $-9.4M | ||
| Q1 24 | $-40.6M | $-15.8M |
| Q4 25 | -63.7% | -11.8% | ||
| Q3 25 | -851.8% | -85.8% | ||
| Q2 25 | -290.2% | -62.8% | ||
| Q1 25 | -1479.6% | -40.5% | ||
| Q4 24 | — | -20.0% | ||
| Q3 24 | -1439.4% | -58.7% | ||
| Q2 24 | -1276.2% | -47.0% | ||
| Q1 24 | -551.5% | -54.7% |
| Q4 25 | -19.9% | -2.5% | ||
| Q3 25 | -637.8% | -78.2% | ||
| Q2 25 | -203.3% | -185.8% | ||
| Q1 25 | -1077.2% | -43.4% | ||
| Q4 24 | — | -63.9% | ||
| Q3 24 | -785.4% | -55.8% | ||
| Q2 24 | -504.3% | -37.7% | ||
| Q1 24 | -408.0% | -65.2% |
| Q4 25 | $-0.03 | $0.04 | ||
| Q3 25 | $-0.19 | $-0.44 | ||
| Q2 25 | $-0.12 | $-1.27 | ||
| Q1 25 | $-0.15 | $-0.42 | ||
| Q4 24 | — | $-0.61 | ||
| Q3 24 | $-0.17 | $-0.66 | ||
| Q2 24 | $-0.13 | $-0.52 | ||
| Q1 24 | $-0.14 | $-0.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $124.5M |
| Total DebtLower is stronger | — | $201.1M |
| Stockholders' EquityBook value | $966.9M | $94.9M |
| Total Assets | $1.4B | $386.2M |
| Debt / EquityLower = less leverage | — | 2.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $124.5M | ||
| Q3 25 | $83.2M | $146.5M | ||
| Q2 25 | $92.4M | $93.8M | ||
| Q1 25 | $159.3M | $75.8M | ||
| Q4 24 | $156.3M | $52.5M | ||
| Q3 24 | $126.6M | $63.2M | ||
| Q2 24 | $148.3M | $41.2M | ||
| Q1 24 | $123.6M | $35.4M |
| Q4 25 | — | $201.1M | ||
| Q3 25 | — | $195.1M | ||
| Q2 25 | — | $122.5M | ||
| Q1 25 | — | $115.3M | ||
| Q4 24 | — | $107.7M | ||
| Q3 24 | — | $98.8M | ||
| Q2 24 | — | $108.6M | ||
| Q1 24 | — | $85.0M |
| Q4 25 | $966.9M | $94.9M | ||
| Q3 25 | $964.0M | $91.1M | ||
| Q2 25 | $1.0B | $86.6M | ||
| Q1 25 | $1.0B | $88.8M | ||
| Q4 24 | $1.1B | $94.0M | ||
| Q3 24 | $1.1B | $110.3M | ||
| Q2 24 | $1.1B | $76.5M | ||
| Q1 24 | $1.1B | $81.7M |
| Q4 25 | $1.4B | $386.2M | ||
| Q3 25 | $1.4B | $380.9M | ||
| Q2 25 | $1.4B | $310.8M | ||
| Q1 25 | $1.3B | $284.9M | ||
| Q4 24 | $1.4B | $254.1M | ||
| Q3 24 | $1.4B | $245.5M | ||
| Q2 24 | $1.4B | $224.3M | ||
| Q1 24 | $1.5B | $210.1M |
| Q4 25 | — | 2.12× | ||
| Q3 25 | — | 2.14× | ||
| Q2 25 | — | 1.41× | ||
| Q1 25 | — | 1.30× | ||
| Q4 24 | — | 1.15× | ||
| Q3 24 | — | 0.90× | ||
| Q2 24 | — | 1.42× | ||
| Q1 24 | — | 1.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-9.3M |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $-9.3M | ||
| Q3 25 | $-52.6M | $-39.0M | ||
| Q2 25 | $-32.4M | $-7.3M | ||
| Q1 25 | $-11.6M | $27.2M | ||
| Q4 24 | $-108.6M | $-1.8M | ||
| Q3 24 | $-28.9M | $1.0M | ||
| Q2 24 | $-30.0M | $-1.8M | ||
| Q1 24 | $-41.7M | $-3.8M |
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | — | ||
| Q2 25 | $-45.8M | — | ||
| Q1 25 | $-22.2M | — | ||
| Q4 24 | $-187.0M | — | ||
| Q3 24 | $-47.4M | — | ||
| Q2 24 | $-50.1M | — | ||
| Q1 24 | $-65.8M | — |
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | — | ||
| Q2 25 | -267.9% | — | ||
| Q1 25 | -524.0% | — | ||
| Q4 24 | -3702.8% | — | ||
| Q3 24 | -728.4% | — | ||
| Q2 24 | -683.8% | — | ||
| Q1 24 | -661.5% | — |
| Q4 25 | 21.9% | — | ||
| Q3 25 | 99.7% | — | ||
| Q2 25 | 78.2% | — | ||
| Q1 25 | 251.1% | — | ||
| Q4 24 | 1552.7% | — | ||
| Q3 24 | 284.6% | — | ||
| Q2 24 | 274.6% | — | ||
| Q1 24 | 242.5% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
